X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1842) 1842
Patent (912) 912
Publication (471) 471
Paper (336) 336
Conference Proceeding (50) 50
Book / eBook (25) 25
Book Chapter (22) 22
Magazine Article (16) 16
Streaming Audio (7) 7
Web Resource (6) 6
Book Review (5) 5
Dissertation (5) 5
Technical Report (5) 5
Report (3) 3
Journal / eJournal (2) 2
Microfilm (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (474) 474
physics (463) 463
performing operations (412) 412
transporting (412) 412
natural sciences (410) 410
naturvetenskap (410) 410
experiment (400) 400
physical sciences (393) 393
fysik (391) 391
high energy physics - experiment (338) 338
particle physics (326) 326
male (324) 324
female (295) 295
physics - high energy physics - experiment (286) 286
medicin och hälsovetenskap (270) 270
medical and health sciences (268) 268
high energy physics (262) 262
crushing, pulverising, or disintegrating (255) 255
crushing, pulverising, or disintegrating in general (255) 255
milling grain (255) 255
preparatory treatment of grain for milling (255) 255
physics, particles & fields (245) 245
electricity (197) 197
middle aged (197) 197
adult (191) 191
index medicus (180) 180
chemistry (179) 179
electric communication technique (173) 173
physics of elementary particles and fields (164) 164
metallurgy (162) 162
aged (158) 158
phenomenology (147) 147
surgery (134) 134
astronomy & astrophysics (130) 130
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (129) 129
particle physics - experiment (123) 123
nuclear experiment (122) 122
general tagging of cross-sectional technologies spanning over several sections of the ipc (116) 116
general tagging of new technological developments (116) 116
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (116) 116
hadron-hadron scattering (109) 109
clinical medicine (97) 97
klinisk medicin (97) 97
wireless communications networks (97) 97
transmission of digital information, e.g. telegraphiccommunication (92) 92
parton distributions (88) 88
human necessities (87) 87
adolescent (86) 86
technical subjects covered by former uspc (86) 86
physics, nuclear (85) 85
transmission (83) 83
technical subjects covered by former us classification (77) 77
animals (76) 76
model (76) 76
subatomär fysik (74) 74
subatomic physics (73) 73
science & technology (72) 72
medicine (71) 71
research (69) 69
treatment outcome (69) 69
organic chemistry (68) 68
mechanical engineering (67) 67
astrophysics (66) 66
ciências físicas [ciências naturais] (66) 66
sweden (65) 65
orthopedics (63) 63
kirurgi (62) 62
medicin (61) 61
peptides (60) 60
lhc (59) 59
aged, 80 and over (58) 58
analysis (58) 58
hygiene (58) 58
medical or veterinary science (58) 58
astronomy, astrophysics and cosmology (57) 57
elementary particles, quantum field theory (57) 57
quantum field theories, string theory (57) 57
venous thromboembolism (57) 57
hematology (56) 56
preparations for medical, dental, or toilet purposes (55) 55
heating (54) 54
risk factors (54) 54
blasting (53) 53
double-blind method (53) 53
health sciences (53) 53
lighting (53) 53
prevention (53) 53
weapons (53) 53
collisions (50) 50
ferrous or non-ferrous alloys (50) 50
hälsovetenskaper (50) 50
pretreatment of raw materials (50) 50
production and refining of metals (50) 50
treatment of alloys or non-ferrous metals (50) 50
high energy astrophysical phenomena (49) 49
detectors (47) 47
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (45) 45
enoxaparin (45) 45
física (45) 45
physics, multidisciplinary (45) 45
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (8) 8
Robarts - Stacks (8) 8
Online Resources - Online (7) 7
UTL at Downsview - May be requested (5) 5
Innis College - Stacks (3) 3
Music - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Map & Data - Map Collection (1) 1
Media Commons - Audio Visual (1) 1
St. Michael's College (John M. Kelly) - Audio Visual (1) 1
Trinity College (John W Graham) - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2637) 2637
French (325) 325
German (167) 167
Swedish (126) 126
Finnish (56) 56
Norwegian (34) 34
Danish (14) 14
Portuguese (13) 13
Russian (12) 12
Spanish (9) 9
Chinese (6) 6
Korean (6) 6
Estonian (5) 5
Icelandic (3) 3
Italian (3) 3
Ukrainian (2) 2
Hungarian (1) 1
Indonesian (1) 1
Latin (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2005, ISBN 9789170185748, v. <1->
Book
2003, European social inclusion, ISBN 0820460818, Volume 9., 176
Book
Lancet, The, ISSN 0140-6736, 2007, Volume 370, Issue 9591, pp. 949 - 956
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 04/2011, Volume 105, Issue 4, pp. 721 - 729
This trial compared the efficacy and safety of oral dabigatran, a direct thrombin inhibitor, versus subcutaneous enoxaparin for extended thromboprophylaxis in... 
Dabigatran etexilate | Oral anticoagulant | Total hip arthroplasty | Venous thromboembolism | Prophylaxis | SURGERY | DIRECT THROMBIN INHIBITOR | FONDAPARINUX | oral anticoagulant | PREVENTION | DEEP-VEIN THROMBOSIS | prophylaxis | total hip arthroplasty | KNEE REPLACEMENT | venous thromboembolism | MOLECULAR-WEIGHT HEPARIN | ETEXILATE | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Venous Thromboembolism - mortality | Anticoagulants - administration & dosage | Humans | Middle Aged | Male | Antithrombins - administration & dosage | Dabigatran | Enoxaparin - adverse effects | Venous Thromboembolism - prevention & control | Enoxaparin - administration & dosage | Benzimidazoles - administration & dosage | Hemorrhage - etiology | Injections, Subcutaneous | Female | Venous Thrombosis - prevention & control | Benzimidazoles - adverse effects | beta-Alanine - analogs & derivatives | Postoperative Complications | beta-Alanine - adverse effects | Double-Blind Method | Administration, Oral | Venous Thrombosis - mortality | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Venous Thrombosis - etiology | Venous Thromboembolism - etiology | Antithrombins - adverse effects | Survival Analysis | Arthroplasty, Replacement, Hip - mortality | Aged | Benzimidazoles | Venous Thrombosis | Oral | Hemorrhage | Antithrombins | Venous Thromboembolism | administration & dosage | Surgery | beta-Alanine | Administration | Anticoagulants | Subcutaneous | Enoxaparin | Arthroplasty | Replacement | prevention & control | Kirurgi | Hip | etiology | Injections | analogs & derivatives | adverse effects | mortality
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 372, Issue 9632, pp. 31 - 39
Summary Background The risk of venous thromboembolism is high after total hip arthroplasty and could persist after hospital discharge. Our aim was to compare... 
Internal Medicine | WEIGHT HEPARIN-PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | PLACEBO | FACTOR-XA INHIBITOR | ORTHOPEDIC-SURGERY | KNEE REPLACEMENT | BAY-59-7939 | THROMBOSIS | PROLONGED THROMBOPROPHYLAXIS | TIME-COURSE | DALTEPARIN | Thiophenes - therapeutic use | Double-Blind Method | Drug Administration Schedule | Thiophenes - adverse effects | Humans | Middle Aged | Morpholines - administration & dosage | Arthroplasty, Replacement, Hip | Male | Thiophenes - administration & dosage | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Fibrinolytic Agents - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Enoxaparin - administration & dosage | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Fibrinolytic Agents - administration & dosage | Morpholines - adverse effects | Morpholines - therapeutic use | Health care | Medical imaging | Hospitals | Protease inhibitors | Surgery | Tomography | Joint surgery | Drug therapy | Patients | Veins & arteries | Index Medicus | Abridged Index Medicus | Thiophenes/administration & dosage/adverse effects/therapeutic use | use | Arthroplasty | Replacement | Venous Thromboembolism/prevention & control | Morpholines/administration & dosage/adverse effects/therapeutic use | Kirurgi | Hip | 80 and over | Enoxaparin/administration & dosage/adverse effects/therapeutic use | Fibrinolytic Agents/administration & dosage/adverse effects/therapeutic
Journal Article
Annual Review of Medicine, ISSN 0066-4219, 02/2011, Volume 62, Issue 1, pp. 41 - 57
Journal Article
Lakartidningen, ISSN 0023-7205, 2018, Volume 115, Issue 49-50, p. 2060
Journal Article
1990, ISBN 0851129218, 432
Book
The American Journal of Sports Medicine, ISSN 0363-5465, 12/2013, Volume 41, Issue 12, pp. 2867 - 2876
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 09/2010, Volume 104, Issue 3, pp. 642 - 649
Edoxaban is a new oral direct factor Xa inhibitor. The purpose of this study was to evaluate the efficacy and safety of different doses of edoxaban for the... 
Thromboprophylaxis | Edoxaban | Anticoagulant therapy | Venous thromboembolism | Factor Xa inhibitor | Dalteparin - administration & dosage | Pulmonary Embolism - prevention & control | Anticoagulants - administration & dosage | Factor Xa Inhibitors | United States | Humans | Middle Aged | Venous Thrombosis - blood | Venous Thrombosis - diagnostic imaging | Male | Thiazoles - administration & dosage | Thiazoles - adverse effects | Venous Thromboembolism - blood | Fibrinolytic Agents - adverse effects | Venous Thromboembolism - prevention & control | Pyridines - adverse effects | Time Factors | Injections, Subcutaneous | Female | Venous Thrombosis - prevention & control | Venous Thromboembolism - diagnostic imaging | Pulmonary Embolism - diagnostic imaging | Pyridines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Administration, Oral | Europe | Risk Factors | Dalteparin - adverse effects | Logistic Models | Treatment Outcome | Anticoagulants - adverse effects | Arthroplasty, Replacement, Hip - adverse effects | Factor Xa - metabolism | Venous Thrombosis - etiology | Phlebography | Pulmonary Embolism - blood | Venous Thromboembolism - etiology | Canada | Pulmonary Embolism - etiology | Aged | Fibrinolytic Agents - administration & dosage | Hemorrhage - chemically induced | Elective Surgical Procedures | Surgery | venous thromboembolism | thromboprophylaxis | Kirurgi | edoxaban | anticoagulant therapy
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2008, Volume 358, Issue 26, pp. 2765 - 2775
Rivaroxaban is an orally administered direct inhibitor of factor Xa. As compared with enoxaparin, rivaroxaban was more effective in preventing venous... 
ORAL XIMELAGATRAN | MEDICINE, GENERAL & INTERNAL | FACTOR-XA INHIBITOR | KNEE REPLACEMENT | BAY-59-7939 | DEEP-VENOUS THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | MAJOR ORTHOPEDIC-SURGERY | DOUBLE-BLIND | PREVENTION | THROMBOEMBOLISM | Thiophenes - therapeutic use | Pulmonary Embolism - prevention & control | Venous Thromboembolism - mortality | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Middle Aged | Male | Enoxaparin - therapeutic use | Pulmonary Embolism - epidemiology | Enoxaparin - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Aged, 80 and over | Adult | Female | Venous Thrombosis - prevention & control | Morpholines - adverse effects | Morpholines - therapeutic use | Double-Blind Method | Anticoagulants - therapeutic use | Arthroplasty, Replacement, Hip | Anticoagulants - adverse effects | Venous Thrombosis - epidemiology | Adolescent | Aged | Enoxaparin | Dosage and administration | Blood coagulation factors | Comparative analysis | Health aspects | Hip joint | Clinical trials | Comparative studies | Joint surgery | Drug therapy | Clinical outcomes | Blood clots | Index Medicus | Abridged Index Medicus | Enoxaparin/adverse effects/therapeutic use | Venous Thrombosis/epidemiology/prevention & control | Thiophenes/adverse effects/therapeutic use | Arthroplasty | Replacement | Kirurgi | Hip | Morpholines/adverse effects/therapeutic use | 80 and over | Surgery | Anticoagulants/adverse effects/therapeutic use | Venous Thromboembolism/mortality/prevention & control | Factor Xa/antagonists & inhibitors | Pulmonary Embolism/epidemiology/prevention & control
Journal Article
Journal Article